25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIVI (Biovie Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biovie Inc together

I guess you are interested in Biovie Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Biovie Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Biovie Inc’s Price Targets

I'm going to help you getting a better view of Biovie Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.

1. Quick Overview

1.1. Quick analysis of Biovie Inc (30 sec.)










1.2. What can you expect buying and holding a share of Biovie Inc? (30 sec.)

How much money do you get?

How much money do you get?
$25,008.37
When do you have the money?
1 year
How often do you get paid?
22.5%

What is your share worth?

Current worth
$1.29
Expected worth in 1 year
$0.52
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$25,007.60
Return On Investment
1,256,663.5%

For what price can you sell your share?

Current Price per Share
$1.99
Expected price per share
$1.75 - $6.5371
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biovie Inc (5 min.)




Live pricePrice per Share (EOD)
$1.99
Intrinsic Value Per Share
$-33.39 - $8.70
Total Value Per Share
$-32.10 - $9.98

2.2. Growth of Biovie Inc (5 min.)




Is Biovie Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$19m$12.3m$7.3m37.2%

How much money is Biovie Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4.3m-$8m$3.6m82.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biovie Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#486 / 845

Most Revenue
#804 / 845

Most Profit
#389 / 845

Most Efficient
#247 / 845
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biovie Inc?

Welcome investor! Biovie Inc's management wants to use your money to grow the business. In return you get a share of Biovie Inc.

First you should know what it really means to hold a share of Biovie Inc. And how you can make/lose money.

Speculation

The Price per Share of Biovie Inc is $1.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biovie Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biovie Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.29. Based on the TTM, the Book Value Change Per Share is $-0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $6,252.09 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biovie Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.24-11.9%-0.53-26.5%-1.07-53.5%-1.02-51.3%-2.01-100.8%-1.14-57.1%
Usd Book Value Change Per Share-1.61-80.8%-0.19-9.7%0.010.3%0.073.3%0.2110.4%0.031.6%
Usd Dividend Per Share25,008.231,256,695.1%6,252.09314,175.6%0.000.0%2,084.03104,725.2%1,251.4962,888.7%625.8031,447.2%
Usd Total Gains Per Share25,006.631,256,614.3%6,251.90314,165.9%0.010.3%2,084.10104,728.5%1,251.6962,899.1%625.8331,448.8%
Usd Price Per Share0.93-1.28-1.40-2.78-5.69-12.24-
Price to Earnings Ratio-0.98--0.68--0.29--0.65--1.84--94.83-
Price-to-Total Gains Ratio0.00--2.73--42.84--15.85--10.83--341.02-
Price to Book Ratio0.72-0.58-1.27-1.48-4.09--33.20-
Price-to-Total Gains Ratio0.00--2.73--42.84--15.85--10.83--341.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.99
Number of shares502
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share6,252.091,251.49
Usd Book Value Change Per Share-0.190.21
Usd Total Gains Per Share6,251.901,251.69
Gains per Quarter (502 shares)3,138,454.27628,349.53
Gains per Year (502 shares)12,553,817.072,513,398.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
112554204-3871255380725129834162513388
225108408-7732510762450259658315026786
337662611-116037661441753894812477540184
450216815-15475021525810051930166210053582
562771019-19346276907512564913207812566980
675325223-23207532289215077895249315080378
787879426-27078787670917590878290917593776
8100433630-309410043052620103860332520107174
9112987834-348011298434322616843374022620572
10125542038-386712553816025129826415625133970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.047.00.02.1%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%10.030.00.025.0%11.037.00.022.9%
Dividend per Share4.00.00.0100.0%4.00.08.033.3%7.00.013.035.0%9.00.031.022.5%9.00.039.018.8%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%9.011.00.045.0%14.026.00.035.0%15.033.00.031.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biovie Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.608-0.193-88%0.006-29313%0.067-2512%0.207-877%0.032-5070%
Book Value Per Share--1.2872.305-44%1.641-22%2.079-38%1.871-31%0.894+44%
Current Ratio--9.0999.576-5%2.053+343%5.232+74%10.555-14%6.201+47%
Debt To Asset Ratio--0.1180.160-26%0.531-78%0.419-72%0.369-68%0.927-87%
Debt To Equity Ratio--0.1340.212-37%1.330-90%1.015-87%0.987-86%1.206-89%
Dividend Per Share--25008.2336252.094+300%-+100%2084.031+1100%1251.485+1898%625.800+3896%
Enterprise Value--28660024.00028990669.350-1%21269585.567+35%36269177.389-21%56172101.853-49%97646149.224-71%
Eps---0.236-0.527+123%-1.065+351%-1.021+332%-2.005+749%-1.137+381%
Ev To Ebitda Ratio---2.091-1.851-11%-0.753-64%-1.283-39%-2.295+10%-106.155+4977%
Free Cash Flow Per Share---0.380-0.540+42%-0.927+144%-0.934+146%-0.756+99%-0.396+4%
Free Cash Flow To Equity Per Share--861390.067215347.494+300%-0.336+100%71782.553+1100%262777.813+228%131388.906+556%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.695----------
Intrinsic Value_10Y_min---33.390----------
Intrinsic Value_1Y_max---1.231----------
Intrinsic Value_1Y_min---3.693----------
Intrinsic Value_3Y_max---2.097----------
Intrinsic Value_3Y_min---10.862----------
Intrinsic Value_5Y_max---1.030----------
Intrinsic Value_5Y_min---17.717----------
Market Cap14999585.200+9%13665691.00011293089.350+21%10550776.067+30%21508281.972-36%43235788.703-68%92459371.224-85%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio1.546+54%0.7190.583+23%1.270-43%1.477-51%4.093-82%-33.198+4719%
Pe Ratio-2.107-115%-0.979-0.678-31%-0.290-70%-0.651-33%-1.837+88%-94.827+9585%
Price Per Share1.990+54%0.9251.276-28%1.400-34%2.780-67%5.692-84%12.244-92%
Price To Free Cash Flow Ratio-1.311-115%-0.609-0.788+29%-0.322-47%-0.733+20%-4.918+707%-806.015+132193%
Price To Total Gains Ratio0.000+54%0.000-2.725+7367876%-42.838+115809845%-15.853+42858470%-10.831+29280525%-341.017+921911854%
Quick Ratio--8.6389.352-8%2.008+330%5.279+64%10.549-18%6.165+40%
Return On Assets---0.162-0.187+16%-0.323+100%-0.285+76%-1.312+711%-0.934+477%
Return On Equity---0.184-0.226+23%-0.821+348%-0.652+255%-1.869+919%-1.172+539%
Total Gains Per Share--25006.6256251.901+300%0.006+454379634%2084.098+1100%1251.692+1898%625.832+3896%
Usd Book Value--19011985.00019704898.500-4%12367826.250+54%16448202.500+16%14571320.250+30%6970465.050+173%
Usd Book Value Change Per Share---1.608-0.193-88%0.006-29313%0.067-2512%0.207-877%0.032-5070%
Usd Book Value Per Share--1.2872.305-44%1.641-22%2.079-38%1.871-31%0.894+44%
Usd Dividend Per Share--25008.2336252.094+300%-+100%2084.031+1100%1251.485+1898%625.800+3896%
Usd Enterprise Value--28660024.00028990669.350-1%21269585.567+35%36269177.389-21%56172101.853-49%97646149.224-71%
Usd Eps---0.236-0.527+123%-1.065+351%-1.021+332%-2.005+749%-1.137+381%
Usd Free Cash Flow---5607467.000-4756301.250-15%-6986256.000+25%-7268592.500+30%-5833350.350+4%-3055134.975-46%
Usd Free Cash Flow Per Share---0.380-0.540+42%-0.927+144%-0.934+146%-0.756+99%-0.396+4%
Usd Free Cash Flow To Equity Per Share--861390.067215347.494+300%-0.336+100%71782.553+1100%262777.813+228%131388.906+556%
Usd Market Cap14999585.200+9%13665691.00011293089.350+21%10550776.067+30%21508281.972-36%43235788.703-68%92459371.224-85%
Usd Price Per Share1.990+54%0.9251.276-28%1.400-34%2.780-67%5.692-84%12.244-92%
Usd Profit---3489141.000-4396535.250+26%-8029957.500+130%-8330164.250+139%-12814769.950+267%-6990994.225+100%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share--25006.6256251.901+300%0.006+454379634%2084.098+1100%1251.692+1898%625.832+3896%
 EOD+6 -2MRQTTM+20 -14YOY+28 -63Y+23 -115Y+21 -1410Y+23 -12

3.3 Fundamental Score

Let's check the fundamental score of Biovie Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.107
Price to Book Ratio (EOD)Between0-11.546
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.638
Current Ratio (MRQ)Greater than19.099
Debt to Asset Ratio (MRQ)Less than10.118
Debt to Equity Ratio (MRQ)Less than10.134
Return on Equity (MRQ)Greater than0.15-0.184
Return on Assets (MRQ)Greater than0.05-0.162
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.985
Ma 20Greater thanMa 501.920
Ma 50Greater thanMa 1001.792
Ma 100Greater thanMa 2005.217
OpenGreater thanClose1.930
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Biovie Inc

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Fundamental data was last updated by Penke on 2025-10-16 19:32:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Biovie Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Biovie Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--77.9%+77.9%
TTM--167.8%+167.8%
YOY--189.1%+189.1%
3Y--264.1%+264.1%
5Y--348.5%+348.5%
10Y--480.7%+480.7%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Biovie Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Biovie Inc to theΒ Biotechnology industry mean.
  • -16.2% Return on Assets means thatΒ Biovie Inc generatedΒ $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biovie Inc:

  • The MRQ is -16.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.2%TTM-18.7%+2.5%
TTM-18.7%YOY-32.3%+13.6%
TTM-18.7%5Y-131.2%+112.4%
5Y-131.2%10Y-93.4%-37.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.2%-12.0%-4.2%
TTM-18.7%-11.9%-6.8%
YOY-32.3%-11.1%-21.2%
3Y-28.5%-12.0%-16.5%
5Y-131.2%-11.7%-119.5%
10Y-93.4%-13.8%-79.6%
4.3.1.3. Return on Equity

Shows how efficient Biovie Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Biovie Inc to theΒ Biotechnology industry mean.
  • -18.4% Return on Equity means Biovie Inc generated $-0.18Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biovie Inc:

  • The MRQ is -18.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.4%TTM-22.6%+4.3%
TTM-22.6%YOY-82.1%+59.5%
TTM-22.6%5Y-186.9%+164.3%
5Y-186.9%10Y-117.2%-69.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.4%-14.3%-4.1%
TTM-22.6%-14.9%-7.7%
YOY-82.1%-15.1%-67.0%
3Y-65.2%-16.7%-48.5%
5Y-186.9%-16.9%-170.0%
10Y-117.2%-19.7%-97.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biovie Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Biovie Inc is operatingΒ .

  • Measures how much profit Biovie Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Biovie Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--157.0%+157.0%
TTM--269.6%+269.6%
YOY--250.7%+250.7%
3Y--248.1%+248.1%
5Y--343.0%+343.0%
10Y--499.9%+499.9%
4.3.2.2. Operating Ratio

Measures how efficient Biovie Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biovie Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.873-1.873
TTM-2.819-2.819
YOY-2.863-2.863
3Y-3.587-3.587
5Y-4.687-4.687
10Y-6.470-6.470
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biovie Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biovie Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 9.10Β means the company has $9.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biovie Inc:

  • The MRQ is 9.099. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.576. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.099TTM9.576-0.476
TTM9.576YOY2.053+7.523
TTM9.5765Y10.555-0.980
5Y10.55510Y6.201+4.355
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0993.414+5.685
TTM9.5763.623+5.953
YOY2.0534.048-1.995
3Y5.2324.437+0.795
5Y10.5555.717+4.838
10Y6.2016.130+0.071
4.4.3.2. Quick Ratio

Measures if Biovie Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Biovie Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 8.64Β means the company can pay off $8.64 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biovie Inc:

  • The MRQ is 8.638. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.352. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.638TTM9.352-0.715
TTM9.352YOY2.008+7.344
TTM9.3525Y10.549-1.197
5Y10.54910Y6.165+4.384
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6382.911+5.727
TTM9.3523.135+6.217
YOY2.0083.808-1.800
3Y5.2794.361+0.918
5Y10.5495.697+4.852
10Y6.1656.524-0.359
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biovie Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Biovie IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Biovie Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12Β means that Biovie Inc assets areΒ financed with 11.8% credit (debt) and the remaining percentage (100% - 11.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Biovie Inc:

  • The MRQ is 0.118. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.160. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.118TTM0.160-0.042
TTM0.160YOY0.531-0.371
TTM0.1605Y0.369-0.209
5Y0.36910Y0.927-0.558
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1180.343-0.225
TTM0.1600.361-0.201
YOY0.5310.332+0.199
3Y0.4190.344+0.075
5Y0.3690.348+0.021
10Y0.9270.378+0.549
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Biovie Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Biovie Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 13.4% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biovie Inc:

  • The MRQ is 0.134. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.212. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.134TTM0.212-0.078
TTM0.212YOY1.330-1.118
TTM0.2125Y0.987-0.775
5Y0.98710Y1.206-0.219
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1340.401-0.267
TTM0.2120.441-0.229
YOY1.3300.427+0.903
3Y1.0150.470+0.545
5Y0.9870.471+0.516
10Y1.2060.518+0.688
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Biovie Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Biovie Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.98 means the investor is paying $-0.98Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biovie Inc:

  • The EOD is -2.107. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.979. Based on the earnings, the company is expensive. -2
  • The TTM is -0.678. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.107MRQ-0.979-1.127
MRQ-0.979TTM-0.678-0.301
TTM-0.678YOY-0.290-0.388
TTM-0.6785Y-1.837+1.159
5Y-1.83710Y-94.827+92.990
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.107-2.861+0.754
MRQ-0.979-2.329+1.350
TTM-0.678-2.715+2.037
YOY-0.290-3.622+3.332
3Y-0.651-3.826+3.175
5Y-1.837-5.998+4.161
10Y-94.827-6.984-87.843
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biovie Inc:

  • The EOD is -1.311. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.609. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.788. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.311MRQ-0.609-0.701
MRQ-0.609TTM-0.788+0.179
TTM-0.788YOY-0.322-0.466
TTM-0.7885Y-4.918+4.130
5Y-4.91810Y-806.015+801.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.311-3.572+2.261
MRQ-0.609-2.922+2.313
TTM-0.788-3.864+3.076
YOY-0.322-4.271+3.949
3Y-0.733-5.269+4.536
5Y-4.918-8.454+3.536
10Y-806.015-9.931-796.084
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Biovie Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 0.72 means the investor is paying $0.72Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biovie Inc:

  • The EOD is 1.546. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.719. Based on the equity, the company is cheap. +2
  • The TTM is 0.583. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.546MRQ0.719+0.828
MRQ0.719TTM0.583+0.136
TTM0.583YOY1.270-0.687
TTM0.5835Y4.093-3.510
5Y4.09310Y-33.198+37.291
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5462.494-0.948
MRQ0.7192.079-1.360
TTM0.5832.256-1.673
YOY1.2702.481-1.211
3Y1.4772.709-1.232
5Y4.0933.839+0.254
10Y-33.1984.585-37.783
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biovie Inc.

4.8.1. Institutions holding Biovie Inc

Institutions are holding 1.477% of the shares of Biovie Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc0.71230536637446355494.4009
2025-03-31Geode Capital Management, LLC0.183201380231461511.8428
2025-03-31UBS Group AG0.066104981114843.0707
2025-03-31SMH Capital Inc.0.05310.00614000000
2025-03-31State Street Corp0.021301602200
2025-03-31Traynor Capital Management, Inc0.02120.001316000160000
2025-03-31Northern Trust Corp0.0203015300-1578-9.3494
2025-03-31Royal Bank of Canada0.015011280278032.7059
2025-03-31Tower Research Capital LLC0.00720.000254123456176.6871
2025-03-31Morgan Stanley - Brokerage Accounts0.006504862-20264-80.6495
2025-06-30SBI Securities Co Ltd0.00380.000128911324.7843
2025-03-31Atlantic Trust Group, LLC0.00240178200
2025-03-31Caitong International Asset Management Co., Limited.0.00150.0008110811080
2025-03-31Spire Wealth Management0.001401050800320
2025-03-31JONES FINANCIAL COMPANIES LLLP0.00080609-990-61.9137
2025-03-31Advisor Group Holdings, Inc.0.0008059800
2025-03-31Bank of America Corp0.0003019094.9724
2025-03-31Steward Partners Investment Advisory, LLC0.0001010000
2025-03-31Tradewinds Capital Management, LLC0.0001010000
2025-03-31BlackRock Inc0.000109700
Total 1.11750.0085841872+463907+55.1%

4.9.2. Funds holding Biovie Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Total Stock Mkt Idx Inv0.6187046616-1018-2.1371
2025-06-30NT Ext Equity Mkt Idx Fd - L0.01880.00021416800
2025-07-31Belfund SICAV Belinvest Equity A USD Acc0.13270.11041000000
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.11090.0001835981210.7592
2025-07-31Fidelity Extended Market Index0.09390.00017078-50-0.7015
2025-06-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00530.0002399859517.4846
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.00450.0003337633760
2025-07-31Fidelity Total Market Index0.03190240100
2025-07-31Fidelity Series Total Market Index0.02640198810.0503
2025-07-31Spartan Extended Market Index Pool F0.0190.00011433503.6153
2025-06-30Northern Trust Extended Eq Market Idx0.00190.00021417-12751-89.9986
2025-06-30NT Ext Equity Mkt Idx Fd - NL0.00140104300
2025-07-31Spartan Total Market Index Pool G0.0108081200
2025-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.00110810-2-0.2463
2025-06-30BNYM Mellon SL Market Completion UC10.00040.0001292-1-0.3413
2025-07-31Fidelity Nasdaq Composite Index0.0031023000
2025-07-31Vanguard U.S. Eq Idx Β£ Acc0.000805711.7857
2025-03-31SSgA U.S. Total Market Index Strategy0.000104212.439
2025-06-30BNYM Mellon NSL Mkt Completion Fund Inst0023527.7778
2025-08-31State St US Extended Mkt Indx NL Cl C0.000101000
Total 1.08180.1117104153-8981-8.6%

5.3. Insider Transactions

Insiders are holding 3.365% of the shares of Biovie Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-30Cuong V DoBUY100017.8
2023-09-05Steve GorlinSELL85630.5
2023-08-22Richard J BermanSELL108035
2023-06-07Richard J BermanSELL59858.1
2023-05-22Richard J BermanSELL50065
2023-03-27Richard J BermanSELL33785.2
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets21,562
Total Liabilities2,550
Total Stockholder Equity19,012
 As reported
Total Liabilities 2,550
Total Stockholder Equity+ 19,012
Total Assets = 21,562

Assets

Total Assets21,562
Total Current Assets20,698
Long-term Assets864
Total Current Assets
Cash And Cash Equivalents 17,545
Net Receivables 2,104
Total Current Assets  (as reported)20,698
Total Current Assets  (calculated)19,649
+/- 1,050
Long-term Assets
Property Plant Equipment 340
Goodwill 346
Intangible Assets 178
Long-term Assets  (as reported)864
Long-term Assets  (calculated)864
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,275
Long-term Liabilities275
Total Stockholder Equity19,012
Total Current Liabilities
Short-term Debt 74
Other Current Liabilities 2,200
Total Current Liabilities  (as reported)2,275
Total Current Liabilities  (calculated)2,275
+/- 0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt275
Long-term Liabilities  (as reported)275
Long-term Liabilities  (calculated)275
+/-0
Total Stockholder Equity
Common Stock7
Retained Earnings -352,144
Total Stockholder Equity (as reported)19,012
Total Stockholder Equity (calculated)-352,137
+/- 371,149
Other
Capital Stock7
Cash and Short Term Investments 17,545
Common Stock Shares Outstanding 14,774
Liabilities and Stockholders Equity 21,562
Net Debt -17,195
Net Invested Capital 19,012
Net Working Capital 18,424
Property Plant and Equipment Gross 340
Short Long Term Debt Total 350



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-30
> Total Assets 
0
446
407
360
333
318
293
282
269
266
250
233
2,719
2,540
2,478
2,452
2,364
2,323
2,246
2,215
2,175
4,208
3,645
2,964
2,574
2,608
2,340
2,309
2,084
14,861
13,460
12,893
6,047
21,978
31,873
26,188
20,115
22,859
47,192
45,183
35,105
23,760
21,490
31,773
25,208
21,238
25,694
24,660
21,562
21,56224,66025,69421,23825,20831,77321,49023,76035,10545,18347,19222,85920,11526,18831,87321,9786,04712,89313,46014,8612,0842,3092,3402,6082,5742,9643,6454,2082,1752,2152,2462,3232,3642,4522,4782,5402,7192332502662692822933183333604074460
   > Total Current Assets 
0
446
407
360
333
318
293
282
269
266
250
233
131
9
5
35
5
22
2
28
46
2,136
1,630
1,007
674
765
554
581
413
13,248
11,903
11,394
4,605
20,594
30,547
24,792
18,780
21,590
45,990
44,047
34,041
22,764
20,562
30,540
24,048
20,151
24,681
23,722
20,698
20,69823,72224,68120,15124,04830,54020,56222,76434,04144,04745,99021,59018,78024,79230,54720,5944,60511,39411,90313,2484135815547656741,0071,6302,1364628222535591312332502662692822933183333604074460
       Cash And Cash Equivalents 
0
446
407
345
333
318
288
279
267
266
250
233
124
9
5
35
5
22
2
28
46
2,136
1,630
972
340
249
3
4
37
13,196
11,876
11,351
4,512
20,488
30,392
24,507
18,642
21,231
45,749
31,276
19,461
21,215
20,227
30,350
23,844
20,023
24,406
23,152
17,545
17,54523,15224,40620,02323,84430,35020,22721,21519,46131,27645,74921,23118,64224,50730,39220,4884,51211,35111,87613,19637432493409721,6302,1364628222535591242332502662672792883183333454074460
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,521
14,478
0
0
0
0
0
0
0
0
0000000014,47812,521000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,104
2,104000000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
14
0
0
5
4
2
1
0
0
7
0
0
0
0
0
0
0
0
0
0
35
334
516
551
577
376
52
27
43
187
106
155
285
276
718
483
250
103
1,549
335
190
204
128
276
570
3,154
3,1545702761282041903351,54910325048371827628515510618743275237657755151633435000000000070012450014000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,588
2,531
2,474
2,416
2,359
2,302
2,244
2,187
0
2,072
2,015
1,958
1,900
1,843
1,786
1,728
1,671
1,614
1,556
1,499
1,442
1,384
1,327
1,397
1,335
1,269
1,202
1,135
1,064
996
929
1,233
1,160
1,087
1,013
939
864
8649391,0131,0871,1601,2339299961,0641,1351,2021,2691,3351,3971,3271,3841,4421,4991,5561,6141,6711,7281,7861,8431,9001,9582,0152,07202,1872,2442,3022,3592,4162,4742,5312,588000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
2,588
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127
118
109
100
91
81
71
60
422
407
391
374
357
340
3403573743914074226071819110010911812700000000000000000000002,588000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,243
2,185
2,128
2,071
2,013
1,956
1,899
1,841
1,784
1,727
1,669
1,612
1,555
1,497
1,440
1,383
1,325
1,268
1,211
1,153
1,096
1,039
981
924
866
809
752
694
637
580
522
465
408
350
293
236
178
1782362933504084655225806376947528098669249811,0391,0961,1531,2111,2681,3251,3831,4401,4971,5551,6121,6691,7271,7841,8411,8991,9562,0132,0712,1282,1852,243000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
0
0
0
0
0
0
0
0
0
0
0000000000555000000000000000000000000000000000000
> Total Liabilities 
0
9
17
3
161
204
247
283
324
373
404
445
803
961
1,151
979
1,207
1,241
1,455
1,660
2,064
183
105
179
443
11,329
4,384
4,654
23,583
266
385
1,491
996
1,744
15,808
16,234
16,444
16,898
21,124
23,464
19,764
16,212
13,999
12,847
9,702
7,171
1,772
2,842
2,550
2,5502,8421,7727,1719,70212,84713,99916,21219,76423,46421,12416,89816,44416,23415,8081,7449961,49138526623,5834,6544,38411,3294431791051832,0641,6601,4551,2411,2079791,15196180344540437332428324720416131790
   > Total Current Liabilities 
0
9
17
3
161
204
247
283
324
373
404
445
803
961
1,151
403
631
665
879
1,084
1,238
183
105
179
443
11,329
4,384
4,654
23,520
203
322
1,428
996
1,260
4,358
4,317
4,169
4,096
7,797
16,004
14,495
13,212
13,981
12,481
9,352
6,838
1,457
2,547
2,275
2,2752,5471,4576,8389,35212,48113,98113,21214,49516,0047,7974,0964,1694,3174,3581,2609961,42832220323,5204,6544,38411,3294431791051831,2381,0848796656314031,15196180344540437332428324720416131790
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
10
0
21
10
35
10
576
25
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
59
78
81
84
6,434
9,150
9,385
10,244
8,050
5,762
3,384
134
141
74
741411343,3845,7628,05010,2449,3859,1506,43484817859000000849473522000002557610351021010000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
10
347
10
576
601
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
0
0
0
0
6,391
9,105
9,339
10,195
7,993
5,701
3,320
0
0
0
0003,3205,7017,99310,1959,3399,1056,39100000000008494735220000060157610347102100000000000000
       Accounts payable 
0
9
0
3
0
2
5
1
1
9
1
1
294
389
506
330
471
468
629
746
884
183
105
179
443
684
1,085
1,300
1,259
203
322
1,428
996
679
1,663
1,206
2
3
3,245
5
3
2,715
3,608
4,410
3,587
3,453
1,383
2,476
0
02,4761,3833,4533,5874,4103,6082,715353,245321,2061,6636799961,4283222031,2591,3001,085684443179105183884746629468471330506389294119115203090
       Other Current Liabilities 
0
0
17
0
161
202
242
283
323
363
404
444
500
572
625
63
125
188
250
313
0
354
0
0
0
10,643
3,247
2,881
21,412
0
0
0
996
581
2,695
3,053
4,089
4,012
4,468
9,570
5,341
1,115
133
4,430
4
1
-60
-71
2,200
2,200-71-60144,4301331,1155,3419,5704,4684,0124,0893,0532,69558199600021,4122,8813,24710,64300035403132501881256362557250044440436332328324220216101700
   > Long-term Liabilities 
0
9
0
3
0
2
5
1
0
9
1
1
0
389
517
576
576
576
576
576
0
826
105
179
443
2
1,137
473
63
63
63
63
0
484
11,450
11,916
12,274
12,802
13,327
7,460
5,270
3,000
18
366
350
333
315
296
275
275296315333350366183,0005,2707,46013,32712,80212,27411,91611,4504840636363634731,137244317910582605765765765765765173890119015203090
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
63
0
0
0
0
12,139
12,725
13,261
0
0
0
0
0
0
0
0
0
0
000000000013,26112,72512,13900006363000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
576
576
576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
484
339
194
48
0
0
0
0
0
0
0
0
0
0
0
0
00000000000048194339484000000000000000576576576000000000000000
> Total Stockholder Equity
0
437
390
357
171
115
46
-1
-54
-107
-155
-211
1,916
1,578
1,327
1,473
1,157
1,082
791
555
111
4,025
3,541
2,785
2,131
-8,721
-2,044
-2,344
-21,499
14,596
13,075
11,402
5,050
20,234
16,065
9,955
3,671
5,961
26,068
21,718
15,340
7,548
7,491
18,926
15,506
14,067
23,923
21,818
19,012
19,01221,81823,92314,06715,50618,9267,4917,54815,34021,71826,0685,9613,6719,95516,06520,2345,05011,40213,07514,596-21,499-2,344-2,044-8,7212,1312,7853,5414,0251115557911,0821,1571,4731,3271,5781,916-211-155-107-54-1461151713573904370
   Common Stock
0
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
10
10
32
32
32
51
65
1
1
1
1
1
1
2
2
2
2
2
3
3
4
4
4
4
6
6
6
7
7
7
77766644443322222111111655132323210109999999999999999990
   Retained Earnings Total Equity0000000000-277,073-261,386-250,9700000-93,353-90,360000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-12
-11
-9
-7
0
-3
-1
0
0
0
0
-10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104,755
0
0
0
0
0
0
0
17
177
0
0
0
0
0
0
0
0
00000000177170000000104,755000000000000000-100000-1-30-7-9-11-120000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,434
104,754
0
0
0
0
254,638
267,344
303,137
0
0
0
0
0
0
0
0
0
0
0000000000303,137267,344254,6380000104,754103,434000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
500
500
514
502
504
506
514
510
514
514
514
2,912
2,925
3,032
3,366
3,483
4,071
4,282
4,739
0
9,251
9,267
9,360
9,342
19,397
19,472
19,539
19,539
101,897
103,434
104,754
229,934
250,658
251,903
252,833
254,638
267,344
303,137
313,812
316,386
319,480
327,825
348,212
349,733
352,770
369,782
370,466
742,298
742,298370,466369,782352,770349,733348,212327,825319,480316,386313,812303,137267,344254,638252,833251,903250,658229,934104,754103,434101,89719,53919,53919,47219,3979,3429,3609,2679,25104,7394,2824,0713,4833,3663,0322,9252,9125145145145105145065045025145005000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-229,377,000
Gross Profit-229,377,000-229,377,000
 
Operating Income (+$)
Gross Profit-229,377,000
Operating Expense-17,837
Operating Income-18,066-229,394,837
 
Operating Expense (+$)
Research Development9,267
Selling General Administrative8,570
Selling And Marketing Expenses0
Operating Expense17,83717,837
 
Net Interest Income (+$)
Interest Income853
Interest Expense-333
Other Finance Cost-0
Net Interest Income520
 
Pretax Income (+$)
Operating Income-18,066
Net Interest Income520
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,912-18,221
EBIT - interestExpense = -18,640
-17,912
-17,579
Interest Expense333
Earnings Before Interest and Taxes (EBIT)-18,307-17,579
Earnings Before Interest and Taxes (EBITDA)-18,066
 
After tax Income (+$)
Income Before Tax-17,912
Tax Provision-0
Net Income From Continuing Ops-17,542-17,912
Net Income-17,912
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses18,066
Total Other Income/Expenses Net155-520
 

Technical Analysis of Biovie Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biovie Inc. The general trend of Biovie Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biovie Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biovie Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biovie Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.05 < 2.05 < 6.5371.

The bearish price targets are: 1.81 > 1.75 > 1.75.

Know someone who trades $BIVI? Share this with them.πŸ‘‡

Biovie Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biovie Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biovie Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biovie Inc. The current macd is -0.06465787.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biovie Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biovie Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biovie Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biovie Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiovie Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biovie Inc. The current adx is 30.46.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biovie Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Biovie Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biovie Inc. The current sar is 2.067936.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biovie Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biovie Inc. The current rsi is 48.99. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biovie Inc Daily Relative Strength Index (RSI) ChartBiovie Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biovie Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biovie Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biovie Inc Daily Stochastic Oscillator ChartBiovie Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biovie Inc. The current cci is 66.02.

Biovie Inc Daily Commodity Channel Index (CCI) ChartBiovie Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biovie Inc. The current cmo is 10.67.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Biovie Inc Daily Chande Momentum Oscillator (CMO) ChartBiovie Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biovie Inc. The current willr is -31.61094225.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biovie Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biovie Inc Daily Williams %R ChartBiovie Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Biovie Inc.

Biovie Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biovie Inc. The current atr is 0.15520329.

Biovie Inc Daily Average True Range (ATR) ChartBiovie Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biovie Inc. The current obv is 18,788,134.

Biovie Inc Daily On-Balance Volume (OBV) ChartBiovie Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biovie Inc. The current mfi is 58.91.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biovie Inc Daily Money Flow Index (MFI) ChartBiovie Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biovie Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-10-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-10-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Biovie Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.985
Ma 20Greater thanMa 501.920
Ma 50Greater thanMa 1001.792
Ma 100Greater thanMa 2005.217
OpenGreater thanClose1.930
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biovie Inc with someone you think should read this too:
  • Are you bullish or bearish on Biovie Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biovie Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biovie Inc.

Receive notifications about Biovie Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.